Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hendrik Bohnenberger"'
Autor:
Florian Rosar, Niklas Schön, Hendrik Bohnenberger, Mark Bartholomä, Tobias Stemler, Stephan Maus, Fadi Khreish, Samer Ezziddin, Andrea Schaefer-Schuler
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-15 (2021)
Abstract Background Dosimetry is of high importance for optimization of patient-individual PSMA-targeted radioligand therapy (PSMA-RLT). The aim of our study was to evaluate and compare the feasibility of different approaches of image-based absorbed
Externí odkaz:
https://doaj.org/article/457c2d32be85495990fec9585f9b8948
Autor:
Fadi Khreish, Andrea Schaefer, Samer Ezziddin, Stephan Maus, Sebastian Dewes, Carsten Ohlmann, Martin Ries, Hendrik Bohnenberger, Mark Bartholomä, Florian Rosar, Johannes Linxweiler
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 47:687-694
There is preliminary evidence for prostate-specific membrane antigen (PSMA) upregulation effects of androgen receptor blockade in prostate cancer. In an attempt to find the best condition for PSMA radioligand therapy in metastatic castration-resistan
Autor:
Matthias Saar, Tobias Stemler, Fadi Khreish, Mark Bartholomä, Florian Rosar, Samer Ezziddin, Niklas Ebert, Hendrik Bohnenberger, Stephan Maus, Martin Ries
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 47:721-728
Up to 30% of patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) never respond or develop resistance to 177Lu-labeled PSMA-targeted radioligand monotherapy. Single-agent PSMA-target
Autor:
Florian, Rosar, Hendrik, Bohnenberger, Euy Sung, Moon, Frank, Rösch, Achim, Denig, Daniel, Vincenz-Zörner, Manuela A, Hoffmann, Fadi, Khreish, Samer, Ezziddin, Mathias, Schreckenberger, Hans-Georg, Buchholz, Andrea, Schaefer-Schuler
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 170
Autor:
Matthias Saar, Niklas Ebert, Fadi Khreish, Samer Ezziddin, Stephan Maus, Tobias Stemler, Mark Bartholomä, Martin Ries, Florian Rosar, Hendrik Bohnenberger
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Up to 30% of patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) never respond or develop resistance to 177Lu-labeled PSMA-targeted radioligand monotherapy. Single-agent PSMA-target
Autor:
Hendrik Bohnenberger, A Schaefer-Schuler, Tobias Stemler, M Bartholomä, Florian Rosar, S Ezziddin, Stephan Maus
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
Fadi Khreish, Samer Ezziddin, K Ribbat, A Schaefer-Schuler, Hendrik Bohnenberger, Martin Ries, Florian Rosar
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
S Ezziddin, Fadi Khreish, Florian Rosar, J Linxweiler, Hendrik Bohnenberger, S Dewes, M Bartholomä, C Ohlmann, Martin Ries, A Schaefer-Schuler, Stephan Maus
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
Manuela A Hoffmann, Samer Ezziddin, Andrea Schaefer-Schuler, Hans-Georg Buchholz, Fadi Khreish, Euy Sung Moon, Frank Rösch, Mathias Schreckenberger, Achim Denig, Daniel Vincenz-Zörner, Florian Rosar, Hendrik Bohnenberger
Publikováno v:
Applied Radiation and Isotopes. 170:109599
44Sc is an increasingly investigated positron emitter for use in positron emission tomography (PET) imaging. However, 44Sc is a non-pure positron emitter, since prompt photons are co-emitted during the decay process. This study investigates coinciden